126 related articles for article (PubMed ID: 6199122)
1. Mechanisms of polyclonal B-cell activation in autoimmune B6-lpr/lpr mice.
Warren RW; Roths JB; Murphy ED; Pisetsky DS
Cell Immunol; 1984 Mar; 84(1):22-31. PubMed ID: 6199122
[TBL] [Abstract][Full Text] [Related]
2. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains.
Warren RW; Caster SA; Roths JB; Murphy ED; Pisetsky DS
Clin Immunol Immunopathol; 1984 Apr; 31(1):65-77. PubMed ID: 6607806
[TBL] [Abstract][Full Text] [Related]
3. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
[TBL] [Abstract][Full Text] [Related]
4. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
Carlsten H; Tarkowski A
Scand J Immunol; 1989 Oct; 30(4):457-62. PubMed ID: 2814366
[TBL] [Abstract][Full Text] [Related]
5. The influence of Yaa on anti-DNA responses of B6-lpr mice.
Pisetsky DS; Klatt C; Dawson D; Roths JB
Clin Immunol Immunopathol; 1985 Dec; 37(3):369-76. PubMed ID: 3931946
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin isotype profile of viable and non viable lymphoid cell chimaeras made with nude athymic lpr (lymphoproliferation) mouse recipients.
Tiberghien F; Jachez B; Montecino-Rodriguez E; Loor F
Autoimmunity; 1992; 11(3):151-8. PubMed ID: 1571477
[TBL] [Abstract][Full Text] [Related]
7. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice.
Klinman DM; Eisenberg RA; Steinberg AD
J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800
[TBL] [Abstract][Full Text] [Related]
8. MHC genes modify systemic autoimmune disease. The role of the I-E locus.
Creech EA; Nakul-Aquaronne D; Reap EA; Cheek RL; Wolthusen PA; Cohen PL; Eisenberg RA
J Immunol; 1996 Jan; 156(2):812-7. PubMed ID: 8543837
[TBL] [Abstract][Full Text] [Related]
9. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity.
Sobel ES; Katagiri T; Katagiri K; Morris SC; Cohen PL; Eisenberg RA
J Exp Med; 1991 Jun; 173(6):1441-9. PubMed ID: 2033370
[TBL] [Abstract][Full Text] [Related]
10. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
11. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
[TBL] [Abstract][Full Text] [Related]
12. Lack of connectivity between the induced and autoimmune repertoires of lpr/lpr mice.
Very DL; Panka DJ; Weissman D; Wysocki L; Manser T; Marshak-Rothstein A
Immunology; 1993 Dec; 80(4):518-26. PubMed ID: 8307604
[TBL] [Abstract][Full Text] [Related]
13. Specificity analysis of monoclonal anti-DNA antibodies from B6-lpr/lpr mice.
Warren RW; Sailstad DM; Caster SA; Pisetsky DS
Arthritis Rheum; 1984 May; 27(5):545-51. PubMed ID: 6721887
[TBL] [Abstract][Full Text] [Related]
14. Partial expression of the lpr locus in the heterozygous state: presence of autoantibodies.
Jachez B; Montecino-Rodriguez E; Fonteneau P; Loor F
Immunology; 1988 May; 64(1):31-6. PubMed ID: 3260217
[TBL] [Abstract][Full Text] [Related]
15. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes.
Rubio CF; Kench J; Russell DM; Yawger R; Nemazee D
J Immunol; 1996 Jul; 157(1):65-71. PubMed ID: 8683157
[TBL] [Abstract][Full Text] [Related]
16. The C57B1/6 nu/nu, lpr/lpr mouse. III. Autoimmunity status.
Mosbach-Ozmen L; Gaveriaux C; Montecino-Rodriguez E; Loor F
Thymus; 1986; 8(1-2):59-75. PubMed ID: 3088780
[TBL] [Abstract][Full Text] [Related]
17. Lymphoid cell transfers between adult C57BL/6 mice differing at the lpr and/or nu locus. Humoral immunity phenotype of the chimeras.
Jachez B; Montecino-Rodriguez E; Pflumio F; Fonteneau P; Loor F
Immunology; 1989 Oct; 68(2):169-74. PubMed ID: 2807374
[TBL] [Abstract][Full Text] [Related]
18. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro and in vivo mitogenic and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A, PWM, PHA and Con A in normal and autoimmune mice.
Dziarski R
J Clin Lab Immunol; 1985 Feb; 16(2):93-109. PubMed ID: 3886911
[TBL] [Abstract][Full Text] [Related]
20. Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr mice.
Shirai A; Aoki I; Otani M; Mond JJ; Klinman DM
J Immunol; 1994 Aug; 153(4):1889-94. PubMed ID: 7519219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
